Tyrosine Pharma, Inc.

Every 40 seconds someone in the US suffers from stroke. Tyrosine Pharma is in development of a therapeutic treatment to reduce brain damage.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Albuquerque, NM, USA
  • Currency USD
  • Founded January 2013
  • Employees 2
  • Website tyrosinepharma.com

Company Summary

Dr. Surojit Paul, the product's inventor, has developed a method and formula to generate a cell-permeable STEP peptide that can bind constitutively to its substrates and is resistant to degradation. Preliminary studies have indicated that intravenous injection of the cell-permeable STEP peptide either before or after an acute ischemic stroke can provide significant protection against ischemic brain injury. ​

Team

  • Wayne Laslie
    CEO

    Former Chief Operating Officer of Myriad Genetics & Myrexis. Over 30 years experience in Pharmaceutical commercialization

  • Alan Kolod
    CFO

    Former CFO of the Future Medical Systems Group (Switzerland). 30+ years in financial management and growing companies and leading them to positive exits.

  • Dr. Surojit Paul
    Technologist

    PhD in Neurosciences. Tenured Professor at University of New Mexico Health Sciences Center

  • Adrian Hobden
    Board Member

    Adrian is a successful pharmaceutical executive with a storied career that started with Glaxo Smith Kline and also included his role as the President of the Pharmaceutical Division of publicly-traded Myriad Genetics and CEO of publicly-traded Myrexis, Inc. a drug development company focused on cancer therapeutics. Adrian is a graduate of Cambridge University in the United Kingdom (UK) and holds a PhD degree in molecular biology from the Universi

Advisors

  • Peacock & Meyers (IP), Candice Lee Owens (Corporate)
    Lawyer
    Unconfirmed
    Thad Porch (Porch CPAs)
    Accountant
    Unconfirmed

Previous Investors

  • New Mexico Angels
    Unconfirmed
    IPHC, LLC
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free